BLNC — Balance Labs Income Statement
0.000.00%
- $5.42m
- $7.21m
- 14
- 61
- 30
- 27
Annual income statement for Balance Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.003 | 1 | 0.625 | 0.247 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.561 | 0.387 | 0.56 | 0.187 | 0.116 |
Operating Profit | -0.558 | 0.613 | 0.064 | 0.06 | -0.116 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.89 | 0.351 | -0.809 | -0.768 | -0.382 |
Net Income After Taxes | -0.89 | 0.351 | -0.809 | -0.768 | -0.382 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.884 | 0.358 | -0.797 | -0.768 | -0.382 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.884 | 0.358 | -0.797 | -0.768 | -0.382 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.041 | 0.017 | -0.029 | -0.039 | -0.018 |